Sony WH-1000XM6 vs. Sennheiser Momentum 5: I wore both pairs for months, and prefer this one ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — A medicine increasingly used to ...

– NociPro enables highly selective nociceptor targeting and potent Na V 1.7 knockdown in rodents and non-human primates, supporting development candidate ETX301 for post‑amputation neuroma pain – – ...

I never thought smart home tech was for me. Maybe that’s because my introduction to it was largely centered around my friends incessantly yelling “Hey Google!” whenever they wanted a light turned on ...

All the Latest Game Footage and Images from Encode Encore! A charming, slice-of-life indie RPG where you earn some sweet cash by trying out various part-time jobs—all in the name of getting your girl ...

Encoded Therapeutics expects to start a pivotal study of its Dravet syndrome gene therapy ETX101 in 2026. (Getty Images) Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78 ...

An unexpected revisit to my earlier post on mouse encoder hacking sparked a timely opportunity to reexamine quadrature encoders, this time with a clearer lens and a more targeted focus on their signal ...

LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles. It plays a role in innate immunity, inflammation regulation and anticancer responses.

Molecules like DNA are capable of storing large amounts of data without requiring an energy source, but accessing this molecular data is expensive and time consuming. Publishing May 16 in the Cell ...

Most of the affected roles will be in Encoded's technology and early-stage R&D functions. (iStock / Getty Images Plus) Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy ...

Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected to keep the biotech operational well into 2026. To extend its cash runway ...